EpiGuard AS is an innovative Norwegian medical technology company established in 2015 by a group of doctors at the Oslo University Hospital with a medical background that ranges from intensive care, infectious diseases, internal medicine, anaesthesiology including transport medicine. After successful recovery of a colleague that contracted Ebola, the group found that existing isolation systems did not provide the necessary protection or treatment options. Their knowledge and expertise made it possible to develop a unique product which in 2020 became the gold standard for transport of patients with highly infectious diseases.
The product is a medical isolation and transportation unit – the EpiShuttle. It provides maximum safety during transport of infectious patients, protecting both patient and the medical personnel. International connections with healthcare professionals and distributors from all around the world and extraordinary efforts of EpiGuards’ team, made the unimaginable possible - over 200 EpiShuttles produced in 2020, and even more planned for this year. Currently, there are more than 300 EpiShuttles in operation assisting healthcare systems around the world in handling the epidemic.
To maintain the high quality level, experts at EpiGuard are constantly developing and improving products while meeting the international standards in the medical transport industry. In 2019, the company received a EUR 2.495.000 grant from the European Union and proved to be worthy of attention in these unstable times. In recent European Commission publication, the EpiShuttle was described as a “life – saving innovation”– an expression on which EpiGuard feels extremely proud and humbled by and continues to be guided by the same core values – safety and protection.
Contact info:
EpiGuard HQ Oslo Science Park, Gaustadalléen 21, 0349 Oslo
Tel: +47 22 12 00 27
Email: info@epiguard.com
Web: www.epiguard.com